Respiratory News and Research

RSS

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

Amid the coronavirus disease (COVID-19) pandemic, many theories have emerged about the disease and the treatments that can in supportive care. A recent theory emerged that suggests non-steroidal anti-inflammatory drugs (NSAIDs) might exacerbate the symptoms of the novel coronavirus. Now, a new study shows that there is no evidence for or against the use of NSAIDS, particularly ibuprofen, for patients with COVID-19.

1 Apr 2020

Antihypertensive drugs may protect against COVID-19 in heart patients

Common drugs used in high blood pressure, heart failure, and diabetic patients with kidney damage, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), could be protective in patients with COVID-19.

31 Mar 2020

Spit and feces test positive for SARS CoV-2 even after recovery

A new study reveals that samples of sputum and feces continue to test positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus even after a person has recovered from COVID-19 and nasopharyngeal secretions test negative for the virus.

31 Mar 2020

Paper-based device to detect coronavirus in wastewater

The coronavirus disease (COVID-19) has spread to180 countries and territories, affecting more than 850,000 people. The transmission of the coronavirus is through respiratory droplets. However, the risk of transmission through feces is low, based on data from previous coronavirus outbreaks. Though transmission of the novel coronavirus through sewerage systems is low, testing could help predict coronavirus outbreaks or spread.

31 Mar 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

UM receives funding for research center dedicated to addressing public health challenges

As emergent pathogens like coronavirus and climate-related health challenges like wildfire smoke plague human populations, the University of Montana has received funding for a center dedicated to understanding and addressing public health challenges to Montana and the region.

31 Mar 2020

TGen ramps up testing for COVID-19 to combat global health threat

Since mid-January, the Translational Genomics Research Institute has joined the world-wide effort to test for the SARS-CoV-2 virus causing the COVID-19 disease.

31 Mar 2020

Stellenbosch University and AzarGen Biotechnologies join forces to tackle COVID-19

Stellenbosch University in South Africa and AzarGen Biotechnologies (Pty) Ltd, a South African biotechnology company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants, have joined forces in the global fight against the coronavirus.

31 Mar 2020

Guidelines and best practices to provide care for seniors during COVID-19 pandemic

Older adults are at elevated risk for complications from COVID-19 and are dying at a higher rate than younger patients.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Understanding the novel coronavirus genome

The novel coronavirus emerged in December 2019 in Wuhan City, Hubei Province, in China, and since then, it has rapidly spread to over 170 countries across the globe. Our knowledge of the virus, now officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is still in the early stages. However, scientists around the world are racing to better understand the virus, in the hope of shedding light on potential vaccines and therapies.

31 Mar 2020

INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing

The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels.

From INTEGRA Biosciences 31 Mar 2020

Eight strains of coronavirus afflicting the world

Scientists around the world are racing to study the novel coronavirus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, it appears that there are eight strains of SARS-CoV-2 circulating the globe. The good news is that according to infectious disease physician and clinical microbiologist Charles Chiu, “The virus mutates so slowly that the virus strains are fundamentally very similar to each other.”

31 Mar 2020

How to boost your immune system to fight coronavirus

As the world struggles with the coronavirus pandemic, more and more people are trying to protect themselves against the virus by all means possible. There are currently no vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), so boosting the immune system by way of diet, regular exercise, and sleep are sensible measures.

31 Mar 2020

Prototype ventilator can help expand respiratory care associated with COVID-19 pandemic

A team led by the University of Illinois at Urbana-Champaign's Grainger College of Engineering and Carle Health has produced a prototype emergency ventilator to help address the expected surge in the need for respiratory care associated with the COVID-19 pandemic.

31 Mar 2020

New mechanical ventilator ready to be manufactured on industrial level

Valencia's Polytechnic University (UPV) has headed the development of a new mechanical ventilator, which is ready to be manufactured on an industrial level, in turn helping supply these devices to hospitals where they can help patients affected by COVID-19.

31 Mar 2020

United States tracking mobile phones to map spread of COVID-19

United States officials are using location data from mobile phone users to track the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is causing the global pandemic of COVID-19. The USA, as of today, has a total of 163,807 cases of COVID-19 and has recorded 3,008 deaths.

30 Mar 2020

Origins of SARS-CoV-2 – natural or man-made?

With over 780,000 individuals across the world infected and over 37,000 dead, the world is gripped by the pandemic caused by the novel strain of coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

30 Mar 2020

COVID-19: What is social distancing?

The coronavirus disease (COVID-19) is a contagious disease caused by a novel coronavirus, akin to previous infections such as severe acute respiratory syndrome (SARS) in 2002 and the Middle East Respiratory Syndrome coronavirus disease (MERS-CoV) in 2012.

30 Mar 2020

Coronavirus shown to spread in high heat and humidity

A new study explores the possibility that the novel coronavirus, which is ravaging the world, can spread in hot and humid conditions, dispelling the view held by some investigators that the virus is more easily transmissible in colder climates.

30 Mar 2020